0.1944EUR+4.29%Mkt Cap: 27.93M EURP/E: —Last update: 2026-05-14
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The compan…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B64.73
P/S2.24
EV/EBITDA-8.34
EV/Revenue2.47
EPS (TTM)-0.03
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-2.45%
FCF Margin-5.48%
Operating CF-589.00K EUR
CapEx (TTM)1.56M EUR
Net Debt/EBITDA-0.79
Net Debt2.92M EUR
Technical
SMA 500.2092 (-7.1%)
SMA 2000.2328 (-16.5%)
Beta0.61
S&P 52W Chg24.23%
Avg Vol (30d)94.51K
Avg Vol (10d)68.78K
Technical Indicators
RSI (14)44.8
MACD-0.0059
MACD Signal-0.0058
MACD Hist.-0.0001
BB Upper0.2180 EUR
BB Middle0.1991 EUR
BB Lower0.1802 EUR
BB Width18.96%
ATR (14)0.0106 EUR
Vol Ratio (20d)0.26x
52W Range
0.080031% of range0.4500
52W High0.4500 EUR
52W Low0.0800 EUR
Profitability
Gross Margin55.27%
EBITDA Margin-29.65%
Profit Margin-35.13%
Oper. Margin-31.13%
ROE-1084.65%
ROA-23.75%
Revenue Growth26.00%
Earnings Growth—
Balance Sheet
Debt/Equity14.66
Current Ratio0.80
Quick Ratio0.39
Book Value/Sh0.0030 EUR
Cash/Share0.0210 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateFeb 3, 2020
Ownership
Shares Out.143.82M
Float49.79M
Insiders66.13%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap27.93M EUR
Enterprise Value30.84M EUR
Revenue (TTM)12.47M EUR
Gross Profit6.89M EUR
Net Income (TTM)-4.38M EUR
Revenue/Share0.0970 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
Last Price0.1944 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—